The Home Infusion Therapy Market was valued at 47.18 billion in 2023 and is expected to reach 66.59 billion by 2031 and grow at a CAGR of 4.4% during the forecast period of 2024-2031.
Home infusion therapy is been recorded as the most effective and productive way of infusing drugs in patients. The basic objective behind home infusion therapy is to monitor and administer the patient’s condition and provide the drugs according to the prescription. This activity is been performed by the visiting nurse, patients, guardians and so forth. There is various list of disease which are been examined in home infusion therapy mostly common disease includes infection, cancer diagnostics dehydration and some other chronic disease related to heart failure.
The rising healthcare expenditure in almost every corner of the world is creating issues for the people. When we give this statement the major reason behind that is, the rising inflation rates is been considered as the major element which is creating problems for the patients. The growing technological advancement in the healthcare industry and the innovations related to the drugs and approval from Food and Drug Association (FDA) regarding the same are creating numerous opportunities for the market to grow during the forecasted period. According to the National Institute of Health (NIH), there are almost 3.2 million who are using home infusion therapy. When we compare the probability of the people who are taking the home infusion therapy the older people who face difficulties in walking or travelling are the ones who are taking more use of the home infusion therapy.
According to healthcare professionals, Covid-19 played a big role in turning hospital-associated therapy into home care infusion therapy, as the pandemic led to several disruptions in patients to have access to hospitals because of the fear related to the coronavirus. And also, the matter of fact the lack of hospital infrastructure gave Home infusion therapy the limelight and an opportunity to increase its awareness. The surveys explain that HIT gives a comfort level to the patients which is also driving the market.
Drivers:
The rising healthcare expenses and the government supportive actions for the Home Infusion Therapy.
According to the Department of Biotechnology Chronic disease is on the rise and is considered as the major reason behind the 73% of all deaths across the globe. Another facts which we would like to mention here is according to NIH the percentage of people suffering from the chronic disease over 50 years old is estimated to increase by 99.5% over the year 2050. The major reason why we are mention the chronic disease data is because the people who are considering the options of the home infusion therapy are most likely to be suffering from chronic disease.
Another factor which is driving the market is because of the supportive government actions for this market. The law which was brought into action on DEC 13, 2016 i.e., 21st Century Cures Act. According to the Section 5012 of that law, Medicare will be provided for the home infusion therapy which will include several benefits.
Restrain:
The stringent rule and regulation related to the drug approvals.
Opportunity :
The rising awareness of the home infusion therapy.
The company which are dealing in this particular market has a wide range of offerings which includes services related to several disease. As we mentioned earlier Covid 19 created an urge of switching the in-hospitals infusion to the home infusions. Currently the companies are focusing more on improving the distribution channels to improve the flow of the drugs and infusion related equipment’s. The rising expansion of the suppliers to provide good services to the patients who are facing geographic constrains is contributing to the growth of the market. Also, the rising technological advancement by the key players of this market related to the digitalization, connected healthcare and so forth.
Challenges :
The shortage of the skilled healthcare experts i.e., nursing staff and the fear related to the global disruptions which impacts the pharmaceutical industry negatively in terms of supply and shortage of drugs.
Healthcare facilities, such as hospitals, clinics, and pharmacies, may sustain damage or experience operational difficulties in immediately affected areas. This may make it more difficult to provide healthcare services, such as home infusion therapy. Because of supply chain disruptions caused by the conflict, it may be challenging to find the home infusion therapy supplies, drugs, and medical equipment you need. Critical resource shortages or delays could result from this.
In conflict-affected areas, medical personnel, particularly specialists in home infusion therapy, may be displaced or compelled to leave. As a result, there might not be enough qualified people available to offer these services.
Impact of Recession :
Patients who require home infusion therapy treatments may have less access to care as a result of a downturn in the industry. This may be the result of things like dwindling access to medical resources, restrictions on insurance coverage, or financial restraints. Patients who depend on home infusion therapy for their treatment and management of chronic diseases may receive subpar care if access to these services is restricted. During a recession, home infusion therapy providers could face financial difficulties. It may be difficult for them to continue operating if there is a decline in the demand for their services, they have trouble getting paid, or they have rising operating costs. This may lead to decreased staffing levels, restricted service options, or possibly the shutdown of some providers of home infusion therapy. These circumstances may also result in fewer opportunities to companies as the commercial buyers may get negatively affected because of the recession.
By Product
Infusion Pumps
Intravenous Sets
IV Cannulas
Needleless Connectors
The product segment is divided in four elements and amongst that Infusion pumps is said to be the segment with the highest share holder. The reason why the infusion pumps will be holding the largest share will be because the infusion pumps has subsegments i.e., Elastomeric, Syringe, Enteral and so forth. The latest development of the infusion pumps and the use of the infusion pumps in several disease is increasing the demand and at the same time increasing the productivity for the healthcare experts in terms of giving proper treatment. The growth of the infusion pumps segment is guaranteed because when we analysed the past records, the use of the smart infusion pumps is been done on greater scale. Also, the adaptability percentage is on the higher side.
By Application
Anti-Infective
Endocrinology
Hydration Therapy
Parenteral Nutrition
Others
.png)
North America is the region which has the highest share compared to the other regions. The rising R&D and the increasing healthcare investment by the commercial and the official organizations is leading the growth of the market in these regions. U.S. is the country which hold the largest share in the North America region, as the rise in the percentage of the older people suffering from chronic and inflammatory disease is increasing which is creating a lot of opportunities for the companies to attract commercial buyers in this region.
APAC is the region with the highest growth rate because of the rising healthcare infrastructure and the rising illness and health related issues in the geriatric population is creating opportunity for the investors.
The major key players are CVS/Coram, BD, Option Care Health, Baxter, Smith’s Medical, B Braun Melsungen Ag, JMS Corp Ltd, Terumo Corp. and others.
BD – The investment of €4 million to open an R&D Centre in Dublin and will also invest additional €30 million in Enniscorthy manufacturing Plant.
Option Care Health – The recent news related to the collaboration between Amedisys and option care health to create a leading and independent platform for the home and alternate site care.
Baxter –The company has officially announced the clearance which it received from FDA for the Novum IQ Syringe Infusion Pump with dose IQ Safety Software.
| Report Attributes | Details |
| Market Size in 2023 | US$ 47.18 Bn |
| Market Size by 2031 | US$ 66.59 Bn |
| CAGR | CAGR of 4.4% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors) • By Indication (Anti-Infective, Endocrinology, Hydration Therapy, Parenteral Nutrition, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | CVS/Coram, BD, Option Care Health, Baxter, Smith’s Medical, B Braun Melsungen Ag, JMS Corp Ltd, Terumo Corp. |
| Key Drivers | • The rising healthcare expenses and the government supportive actions for the Home Infusion Therapy. |
| Market Opportunities | • The rising awareness of the home infusion therapy. |
Ans: The rising healthcare expenses and the government support supportive actions for the home infusion therapy.
Ans: The Home Infusion Therapy Market was valued at 45.20 billion in 2022 and is expected to reach 62.81 billion by 2030 and grow at a CAGR of 4.2% during the forecast period of 2023-2030.
Ans: North America region will dominate the market.
Ans: Patients who require home infusion therapy treatments may have less access to care as a result of a downturn in the industry.
Ans: The major key players are CVS/Coram, BD, Option Care Health, Baxter, Smith’s Medical, B Braun Melsungen Ag, JMS Corp Ltd, Terumo Corp. and others.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Home Infusion Therapy Segmentation, by Product
8.1 Infusion Pumps
8.2 Intravenous Sets
8.3 IV Cannulas
8.4 Needleless Connectors
9. Home Infusion Therapy Segmentation, by Applications
9.1 Anti-Infective
9.2 Endocrinology
9.3 Hydration Therapy
9.4 Parenteral Nutrition
9.5 Others
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Home Infusion Therapy by country
10.2.2North America Home Infusion Therapy by Product
10.2.3 North America Home Infusion Therapy by Application
10.2.4 USA
10.2.4.1 USA Home Infusion Therapy by Product
10.2.4.2 USA Home Infusion Therapy by Application
10.2.5 Canada
10.2.5.1 Canada Home Infusion Therapy by Product
10.2.5.2 Canada Home Infusion Therapy by Application
10.2.6 Mexico
10.2.6.1 Mexico Home Infusion Therapy by Product
10.2.6.2 Mexico Home Infusion Therapy by Application
10.3 Europe
10.3.1 Europe Home Infusion Therapy by country
1.3.3.2 Europe Home Infusion Therapy by Product
10.3.3 Europe Home Infusion Therapy by Application
10.3.4 Germany
10.3.4.1 Germany Home Infusion Therapy by Product
10.3.4.2 Germany Home Infusion Therapy by Application
10.3.5 UK
10.3.5.1 UK Home Infusion Therapy by Product
10.3.5.2 UK Home Infusion Therapy by Application
10.3.6 France
10.3.6.1 France Home Infusion Therapy by Product
10.3.6.2 France Home Infusion Therapy by Application
10.3.7 Italy
10.3.7.1 Italy Home Infusion Therapy by Product
10.3.7.2 Italy Home Infusion Therapy by Application
10.3.8 Spain
10.3.8.1 Spain Home Infusion Therapy by Product
10.3.8.2 Spain Home Infusion Therapy by Application
10.3.9 The Netherlands
10.3.9.1 Netherlands Home Infusion Therapy by Product
10.3.9.2 Netherlands Home Infusion Therapy by Application
10.3.10 Rest of Europe
10.3.10.1 Rest of Europe Home Infusion Therapy by Product
10.3.10.2 Rest of Europe Home Infusion Therapy by Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Home Infusion Therapy by country
10.4.2 Asia Pacific Home Infusion Therapy by Product
10.4.3 Asia Pacific Home Infusion Therapy by Application
10.4.4 Japan
10.4.4.1 Japan Home Infusion Therapy by Product
10.4.4.2 Japan Home Infusion Therapy by Application
10.4.5 South Korea
10.4.5.1 South Korea Home Infusion Therapy by Product
10.4.5.2 South Korea Home Infusion Therapy by Application
10.4.6 China
10.4.6.1 China Home Infusion Therapy by Product
10.4.6.2 China Home Infusion Therapy by Application
10.4.7 India
10.4.7.1 India Home Infusion Therapy by Product
10.4.7.2 India Home Infusion Therapy by Application
10.4.8 Australia
10.4.8.1 Australia Home Infusion Therapy by Product
10.4.8.2 Australia Home Infusion Therapy by Application
10.4.9 Rest of Asia-Pacific
10.4.9.1 APAC Home Infusion Therapy by Product
10.4.9.2 APAC Home Infusion Therapy by Application
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Home Infusion Therapy by country
10.5.2 The Middle East & Africa Home Infusion Therapy by Product
10.5.3 The Middle East & Africa Home Infusion Therapy by Application
10.5.4 Israel
10.5.4.1 Israel Home Infusion Therapy by Product
10.5.4.2 Israel Home Infusion Therapy by Application
10.5.5 UAE
10.5.5.1 UAE Home Infusion Therapy by Product
10.5.5.2 UAE Home Infusion Therapy by Application
10.5.6 South Africa
10.5.6.1 South Africa Home Infusion Therapy by Product
10.5.6.2 South Africa Home Infusion Therapy by Application
10.5.7 Rest of Middle East & Africa
10.5.7.1 Rest of Middle East & Asia Home Infusion Therapy by Product
10.5.7.2 Rest of Middle East & Asia Home Infusion Therapy by Application
10.6 Latin America
10.6.1 Latin America Home Infusion Therapy by country
10.6.2 Latin America Home Infusion Therapy by Product
10.6.3 Latin America Home Infusion Therapy by Application
10.6.4 Brazil
10.6.4.1 Brazil Home Infusion Therapy by Product
10.6.4.2 Brazil Africa Home Infusion Therapy by Application
10.6.5 Argentina
10.6.5.1 Argentina Home Infusion Therapy by Product
10.6.5.2 Argentina Home Infusion Therapy by Application
10.6.6 Rest of Latin America
10.6.6.1 Rest of Latin America Home Infusion Therapy by Product
10.6.6.2 Rest of Latin America Home Infusion Therapy by Application
11. Company Profile
11.1 CVS/Coram
11.1.1 Market Overview
11.1.2 Financials
11.1.3 Product/Services/Offerings
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 BD
11.2.1 Market Overview
11.2.2 Financials
11.2.3 Product/Services/Offerings
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Option Care Health
11.3.1 Market Overview
11.3.2 Financials
11.3.3 Product/Services/Offerings
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Baxter
11.4.1 Market Overview
11.4.2 Financials
11.4.3 Product/Services/Offerings
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Smith’s Medical
11.5.1 Market Overview
11.5.2 Financials
11.5.3 Product/Services/Offerings
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 B Braun Melsungen Ag
11.6.1 Market Overview
11.6.2 Financials
11.6.3 Product/Services/Offerings
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 JMS Corp Ltd
11.7.1 Market Overview
11.7.2 Financials
11.7.3 Product/Services/Offerings
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Terumo Corp
11.8.1 Market Overview
11.8.2 Financials
11.8.3 Product/Services/Offerings
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Others
11.9.1 Market Overview
11.9.2 Financials
11.9.3 Product/Services/Offerings
11.9.4 SWOT Analysis
11.9.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share analysis
12.3 Recent Developments
13. Use Cases and Practice’s
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The ECG Equipment and Management System market is anticipated to arrive at USD 9.77 billion by 2030. From 2023 to 2030, the market is assessed to develop at a CAGR of 6.38%.
The Dyspnea Treatment Market size was estimated USD 6.1 billion in 2022 and is expected to reach USD 10.2 billion by 2030 at a CAGR of 6.7% during the forecast period of 2023-2030.
The Bio Decontamination Market size was estimated USD 225 million in 2022 and is expected to reach USD 410.3 million by 2030 at a CAGR of 7.8% during the forecast period of 2023-2030.
The Urgent Care Apps Market Size was valued at USD 1236 million in 2022 and is expected to reach USD 2254 million by 2030 and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The Orthopedic Software Market Size was assessed at USD 363.32 million in 2022, and is predicted to increase at a CAGR of 8.1 percent from 2023 to 2030, to reach USD 677.48 million.
The Medical Image Analysis Software Market Size was valued at USD 3 billion in 2022 and is expected to reach USD 5.27 billion by 2030 and grow at a CAGR of 7.3% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
